380 related articles for article (PubMed ID: 24236947)
1. GluN2C/GluN2D subunit-selective NMDA receptor potentiator CIQ reverses MK-801-induced impairment in prepulse inhibition and working memory in Y-maze test in mice.
Suryavanshi PS; Ugale RR; Yilmazer-Hanke D; Stairs DJ; Dravid SM
Br J Pharmacol; 2014 Feb; 171(3):799-809. PubMed ID: 24236947
[TBL] [Abstract][Full Text] [Related]
2. Antipsychotic-like profile of CIQ isomers in animal models of schizophrenia.
Gawai P; Upadhyay R; Gakare SG; Sarode L; Dravid SM; Ugale RR
Behav Pharmacol; 2020 Sep; 31(6):524-534. PubMed ID: 31860561
[TBL] [Abstract][Full Text] [Related]
3. Differential effect of NMDA receptor GluN2C and GluN2D subunit ablation on behavior and channel blocker-induced schizophrenia phenotypes.
Shelkar GP; Pavuluri R; Gandhi PJ; Ravikrishnan A; Gawande DY; Liu J; Stairs DJ; Ugale RR; Dravid SM
Sci Rep; 2019 May; 9(1):7572. PubMed ID: 31110197
[TBL] [Abstract][Full Text] [Related]
4. Metformin reverses the schizophrenia-like behaviors induced by MK-801 in rats.
Wang X; Luo C; Mao XY; Li X; Yin JY; Zhang W; Zhou HH; Liu ZQ
Brain Res; 2019 Sep; 1719():30-39. PubMed ID: 31121159
[TBL] [Abstract][Full Text] [Related]
5. N-aryl piperazine metabotropic glutamate receptor 5 positive allosteric modulators possess efficacy in preclinical models of NMDA hypofunction and cognitive enhancement.
Gregory KJ; Herman EJ; Ramsey AJ; Hammond AS; Byun NE; Stauffer SR; Manka JT; Jadhav S; Bridges TM; Weaver CD; Niswender CM; Steckler T; Drinkenburg WH; Ahnaou A; Lavreysen H; Macdonald GJ; Bartolomé JM; Mackie C; Hrupka BJ; Caron MG; Daigle TL; Lindsley CW; Conn PJ; Jones CK
J Pharmacol Exp Ther; 2013 Nov; 347(2):438-57. PubMed ID: 23965381
[TBL] [Abstract][Full Text] [Related]
6. A competitive antagonist of NMDA receptors CGP 40116 attenuates experimental symptoms of schizophrenia evoked by MK-801.
Zajaczkowski W; Czyrak A; Wedzony K
Pol J Pharmacol; 2003; 55(5):703-11. PubMed ID: 14704466
[TBL] [Abstract][Full Text] [Related]
7. Involvement of the N-methyl-D-aspartate receptor GluN2D subunit in phencyclidine-induced motor impairment, gene expression, and increased Fos immunoreactivity.
Yamamoto H; Kamegaya E; Sawada W; Hasegawa R; Yamamoto T; Hagino Y; Takamatsu Y; Imai K; Koga H; Mishina M; Ikeda K
Mol Brain; 2013 Dec; 6():56. PubMed ID: 24330819
[TBL] [Abstract][Full Text] [Related]
8. The D2-family receptor agonist bromocriptine but, not nicotine, reverses NMDA receptor antagonist-induced working memory deficits in the radial arm maze in mice.
MacQueen DA; Young JW
Neurobiol Learn Mem; 2020 Feb; 168():107159. PubMed ID: 31911198
[TBL] [Abstract][Full Text] [Related]
9. CIQ, a positive allosteric modulator of GluN2C/D-containing N-methyl-d-aspartate receptors, rescues striatal synaptic plasticity deficit in a mouse model of Parkinson's disease.
Nouhi M; Zhang X; Yao N; Chergui K
CNS Neurosci Ther; 2018 Feb; 24(2):144-153. PubMed ID: 29230960
[TBL] [Abstract][Full Text] [Related]
10. A Novel Negative Allosteric Modulator Selective for GluN2C/2D-Containing NMDA Receptors Inhibits Synaptic Transmission in Hippocampal Interneurons.
Swanger SA; Vance KM; Acker TM; Zimmerman SS; DiRaddo JO; Myers SJ; Bundgaard C; Mosley CA; Summer SL; Menaldino DS; Jensen HS; Liotta DC; Traynelis SF
ACS Chem Neurosci; 2018 Feb; 9(2):306-319. PubMed ID: 29043770
[TBL] [Abstract][Full Text] [Related]
11. 1-Methyl-1,2,3,4-tetrahydroisoquinoline antagonizes a rise in brain dopamine metabolism, glutamate release in frontal cortex and locomotor hyperactivity produced by MK-801 but not the disruptions of prepulse inhibition, and impairment of working memory in rat.
Pietraszek M; Michaluk J; Romańska I; Wasik A; Gołembiowska K; Antkiewicz-Michaluk L
Neurotox Res; 2009 Nov; 16(4):390-407. PubMed ID: 19649683
[TBL] [Abstract][Full Text] [Related]
12. GluN2D-Containing N-methyl-d-Aspartate Receptors Mediate Synaptic Transmission in Hippocampal Interneurons and Regulate Interneuron Activity.
Perszyk RE; DiRaddo JO; Strong KL; Low CM; Ogden KK; Khatri A; Vargish GA; Pelkey KA; Tricoire L; Liotta DC; Smith Y; McBain CJ; Traynelis SF
Mol Pharmacol; 2016 Dec; 90(6):689-702. PubMed ID: 27625038
[TBL] [Abstract][Full Text] [Related]
13. The mGlu₅ positive allosteric modulator LSN2463359 differentially modulates motor, instrumental and cognitive effects of NMDA receptor antagonists in the rat.
Gastambide F; Gilmour G; Robbins TW; Tricklebank MD
Neuropharmacology; 2013 Jan; 64():240-7. PubMed ID: 22884612
[TBL] [Abstract][Full Text] [Related]
14. PTC-174, a positive allosteric modulator of NMDA receptors containing GluN2C or GluN2D subunits.
Yi F; Rouzbeh N; Hansen KB; Xu Y; Fanger CM; Gordon E; Paschetto K; Menniti FS; Volkmann RA
Neuropharmacology; 2020 Aug; 173():107971. PubMed ID: 31987864
[TBL] [Abstract][Full Text] [Related]
15. The GluN2C/D-specific positive allosteric modulator CIQ rescues delay-induced working memory deficits in mice.
Dembeck M; Dieterich DC; Fendt M
Behav Brain Res; 2024 Jan; 456():114716. PubMed ID: 37839756
[TBL] [Abstract][Full Text] [Related]
16. Allosteric modulation of GluN2C/GluN2D-containing NMDA receptors bidirectionally modulates dopamine release: implication for Parkinson's disease.
Zhang X; Feng ZJ; Chergui K
Br J Pharmacol; 2014 Aug; 171(16):3938-45. PubMed ID: 24818560
[TBL] [Abstract][Full Text] [Related]
17. Long-term behavioral and NMDA receptor effects of young-adult corticosterone treatment in BDNF heterozygous mice.
Klug M; Hill RA; Choy KH; Kyrios M; Hannan AJ; van den Buuse M
Neurobiol Dis; 2012 Jun; 46(3):722-31. PubMed ID: 22426399
[TBL] [Abstract][Full Text] [Related]
18. Discrimination of motor and sensorimotor effects of phencyclidine and MK-801: Involvement of GluN2C-containing NMDA receptors in psychosis-like models.
Tarrés-Gatius M; López-Hill X; Miquel-Rio L; Castarlenas L; Fabius S; Santana N; Vilaró MT; Artigas F; Scorza MC; Castañé A
Neuropharmacology; 2022 Aug; 213():109079. PubMed ID: 35561792
[TBL] [Abstract][Full Text] [Related]
19. Distinct GluN1 and GluN2 Structural Determinants for Subunit-Selective Positive Allosteric Modulation of
Strong KL; Epplin MP; Ogden KK; Burger PB; Kaiser TM; Wilding TJ; Kusumoto H; Camp CR; Shaulsky G; Bhattacharya S; Perszyk RE; Menaldino DS; McDaniel MJ; Zhang J; Le P; Banke TG; Hansen KB; Huettner JE; Liotta DC; Traynelis SF
ACS Chem Neurosci; 2021 Jan; 12(1):79-98. PubMed ID: 33326224
[No Abstract] [Full Text] [Related]
20. Modulation of burst firing of neurons in nucleus reticularis of the thalamus by GluN2C-containing NMDA receptors.
Liu J; Shelkar GP; Zhao F; Clausen RP; Dravid SM
Mol Pharmacol; 2019 Jun; 96(2):193-203. PubMed ID: 31160332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
